nodes	percent_of_prediction	percent_of_DWPC	metapath
Cladribine—ABCG2—Vemurafenib—melanoma	0.159	0.498	CbGbCtD
Cladribine—ABCG2—Dactinomycin—melanoma	0.106	0.331	CbGbCtD
Cladribine—ABCG2—Docetaxel—melanoma	0.0547	0.171	CbGbCtD
Cladribine—POLE3—hair follicle—melanoma	0.00821	0.0828	CbGeAlD
Cladribine—POLE4—skin of body—melanoma	0.00735	0.0741	CbGeAlD
Cladribine—POLE2—mammalian vulva—melanoma	0.00586	0.0591	CbGeAlD
Cladribine—PNP—Paclitaxel—Docetaxel—melanoma	0.00543	1	CbGdCrCtD
Cladribine—POLE4—head—melanoma	0.0048	0.0484	CbGeAlD
Cladribine—RRM2B—eye—melanoma	0.00434	0.0437	CbGeAlD
Cladribine—RRM1—hair follicle—melanoma	0.00429	0.0432	CbGeAlD
Cladribine—POLE3—eye—melanoma	0.0041	0.0413	CbGeAlD
Cladribine—RRM2B—mammalian vulva—melanoma	0.00344	0.0347	CbGeAlD
Cladribine—POLE3—mammalian vulva—melanoma	0.00325	0.0328	CbGeAlD
Cladribine—SLC28A3—mammalian vulva—melanoma	0.00304	0.0307	CbGeAlD
Cladribine—POLE2—lymph node—melanoma	0.00294	0.0296	CbGeAlD
Cladribine—POLA1—retina—melanoma	0.00267	0.0269	CbGeAlD
Cladribine—PNP—head—melanoma	0.00265	0.0267	CbGeAlD
Cladribine—POLE—mammalian vulva—melanoma	0.00248	0.025	CbGeAlD
Cladribine—RRM2B—head—melanoma	0.00246	0.0248	CbGeAlD
Cladribine—POLE3—head—melanoma	0.00233	0.0235	CbGeAlD
Cladribine—NR5A1—head—melanoma	0.00225	0.0227	CbGeAlD
Cladribine—RRM2—skin of body—melanoma	0.00224	0.0226	CbGeAlD
Cladribine—RRM1—eye—melanoma	0.00214	0.0216	CbGeAlD
Cladribine—POLA1—mammalian vulva—melanoma	0.00214	0.0216	CbGeAlD
Cladribine—RRM1—retina—melanoma	0.00212	0.0214	CbGeAlD
Cladribine—RRM2—mammalian vulva—melanoma	0.00204	0.0206	CbGeAlD
Cladribine—RRM1—skin of body—melanoma	0.00186	0.0188	CbGeAlD
Cladribine—POLE—head—melanoma	0.00178	0.0179	CbGeAlD
Cladribine—RRM2B—lymph node—melanoma	0.00172	0.0174	CbGeAlD
Cladribine—RRM1—mammalian vulva—melanoma	0.0017	0.0171	CbGeAlD
Cladribine—DCK—retina—melanoma	0.00165	0.0166	CbGeAlD
Cladribine—POLE3—lymph node—melanoma	0.00163	0.0164	CbGeAlD
Cladribine—RRM2—head—melanoma	0.00146	0.0147	CbGeAlD
Cladribine—DCK—mammalian vulva—melanoma	0.00132	0.0133	CbGeAlD
Cladribine—POLE—lymph node—melanoma	0.00124	0.0125	CbGeAlD
Cladribine—RRM1—head—melanoma	0.00121	0.0122	CbGeAlD
Cladribine—POLA1—lymph node—melanoma	0.00107	0.0108	CbGeAlD
Cladribine—RRM2—lymph node—melanoma	0.00102	0.0103	CbGeAlD
Cladribine—DCK—head—melanoma	0.000943	0.00951	CbGeAlD
Cladribine—RRM1—lymph node—melanoma	0.00085	0.00857	CbGeAlD
Cladribine—SLC22A1—head—melanoma	0.000804	0.00811	CbGeAlD
Cladribine—ABCG2—mammalian vulva—melanoma	0.000735	0.00742	CbGeAlD
Cladribine—DCK—lymph node—melanoma	0.00066	0.00666	CbGeAlD
Cladribine—Chills—Bleomycin—melanoma	0.000528	0.00187	CcSEcCtD
Cladribine—Hepatobiliary disease—Temozolomide—melanoma	0.000523	0.00185	CcSEcCtD
Cladribine—Alopecia—Bleomycin—melanoma	0.00052	0.00184	CcSEcCtD
Cladribine—Erythema multiforme—Dactinomycin—melanoma	0.000519	0.00184	CcSEcCtD
Cladribine—Haemoglobin—Carmustine—melanoma	0.000517	0.00183	CcSEcCtD
Cladribine—Haemorrhage—Carmustine—melanoma	0.000514	0.00182	CcSEcCtD
Cladribine—Erythema—Bleomycin—melanoma	0.000513	0.00181	CcSEcCtD
Cladribine—Hypersensitivity—Vemurafenib—melanoma	0.000509	0.0018	CcSEcCtD
Cladribine—Oedema peripheral—Carmustine—melanoma	0.000506	0.00179	CcSEcCtD
Cladribine—Connective tissue disorder—Carmustine—melanoma	0.000505	0.00179	CcSEcCtD
Cladribine—Atrial fibrillation—Docetaxel—melanoma	0.000504	0.00178	CcSEcCtD
Cladribine—Renal impairment—Docetaxel—melanoma	0.000502	0.00177	CcSEcCtD
Cladribine—Haemoglobin—Temozolomide—melanoma	0.000499	0.00177	CcSEcCtD
Cladribine—Haemorrhage—Temozolomide—melanoma	0.000497	0.00176	CcSEcCtD
Cladribine—Asthenia—Vemurafenib—melanoma	0.000495	0.00175	CcSEcCtD
Cladribine—Pharyngitis—Temozolomide—melanoma	0.000493	0.00174	CcSEcCtD
Cladribine—Chills—Dactinomycin—melanoma	0.000493	0.00174	CcSEcCtD
Cladribine—Urinary tract disorder—Temozolomide—melanoma	0.00049	0.00173	CcSEcCtD
Cladribine—Oedema peripheral—Temozolomide—melanoma	0.000489	0.00173	CcSEcCtD
Cladribine—Cardiac failure—Docetaxel—melanoma	0.000489	0.00173	CcSEcCtD
Cladribine—Pruritus—Vemurafenib—melanoma	0.000488	0.00173	CcSEcCtD
Cladribine—Connective tissue disorder—Temozolomide—melanoma	0.000488	0.00173	CcSEcCtD
Cladribine—Lethargy—Docetaxel—melanoma	0.000487	0.00172	CcSEcCtD
Cladribine—Urethral disorder—Temozolomide—melanoma	0.000487	0.00172	CcSEcCtD
Cladribine—Alopecia—Dactinomycin—melanoma	0.000485	0.00172	CcSEcCtD
Cladribine—Eye disorder—Carmustine—melanoma	0.00048	0.0017	CcSEcCtD
Cladribine—Erythema—Dactinomycin—melanoma	0.000478	0.00169	CcSEcCtD
Cladribine—Pain in extremity—Docetaxel—melanoma	0.000477	0.00169	CcSEcCtD
Cladribine—Ill-defined disorder—Bleomycin—melanoma	0.000476	0.00168	CcSEcCtD
Cladribine—Anaemia—Bleomycin—melanoma	0.000474	0.00167	CcSEcCtD
Cladribine—Diarrhoea—Vemurafenib—melanoma	0.000472	0.00167	CcSEcCtD
Cladribine—Erythema multiforme—Temozolomide—melanoma	0.00047	0.00166	CcSEcCtD
Cladribine—Eye disorder—Temozolomide—melanoma	0.000464	0.00164	CcSEcCtD
Cladribine—Malaise—Bleomycin—melanoma	0.000462	0.00163	CcSEcCtD
Cladribine—Cardiac disorder—Temozolomide—melanoma	0.000461	0.00163	CcSEcCtD
Cladribine—Arrhythmia—Carmustine—melanoma	0.000459	0.00162	CcSEcCtD
Cladribine—Dizziness—Vemurafenib—melanoma	0.000457	0.00161	CcSEcCtD
Cladribine—Alopecia—Carmustine—melanoma	0.000454	0.00161	CcSEcCtD
Cladribine—Angiopathy—Temozolomide—melanoma	0.000451	0.00159	CcSEcCtD
Cladribine—Mental disorder—Carmustine—melanoma	0.00045	0.00159	CcSEcCtD
Cladribine—Ataxia—Docetaxel—melanoma	0.000449	0.00159	CcSEcCtD
Cladribine—Immune system disorder—Temozolomide—melanoma	0.000449	0.00159	CcSEcCtD
Cladribine—Mediastinal disorder—Temozolomide—melanoma	0.000448	0.00158	CcSEcCtD
Cladribine—Malnutrition—Carmustine—melanoma	0.000447	0.00158	CcSEcCtD
Cladribine—Erythema—Carmustine—melanoma	0.000447	0.00158	CcSEcCtD
Cladribine—Cough—Bleomycin—melanoma	0.000447	0.00158	CcSEcCtD
Cladribine—Chills—Temozolomide—melanoma	0.000446	0.00158	CcSEcCtD
Cladribine—Ill-defined disorder—Dactinomycin—melanoma	0.000444	0.00157	CcSEcCtD
Cladribine—Anaemia—Dactinomycin—melanoma	0.000442	0.00156	CcSEcCtD
Cladribine—Vomiting—Vemurafenib—melanoma	0.000439	0.00155	CcSEcCtD
Cladribine—Alopecia—Temozolomide—melanoma	0.000439	0.00155	CcSEcCtD
Cladribine—Chest pain—Bleomycin—melanoma	0.000436	0.00154	CcSEcCtD
Cladribine—Myalgia—Bleomycin—melanoma	0.000436	0.00154	CcSEcCtD
Cladribine—Rash—Vemurafenib—melanoma	0.000435	0.00154	CcSEcCtD
Cladribine—Mental disorder—Temozolomide—melanoma	0.000435	0.00154	CcSEcCtD
Cladribine—Dermatitis—Vemurafenib—melanoma	0.000435	0.00154	CcSEcCtD
Cladribine—Back pain—Carmustine—melanoma	0.000433	0.00153	CcSEcCtD
Cladribine—Headache—Vemurafenib—melanoma	0.000433	0.00153	CcSEcCtD
Cladribine—Erythema—Temozolomide—melanoma	0.000432	0.00153	CcSEcCtD
Cladribine—Malnutrition—Temozolomide—melanoma	0.000432	0.00153	CcSEcCtD
Cladribine—Discomfort—Bleomycin—melanoma	0.000431	0.00152	CcSEcCtD
Cladribine—Malaise—Dactinomycin—melanoma	0.000431	0.00152	CcSEcCtD
Cladribine—Toxic epidermal necrolysis—Docetaxel—melanoma	0.00043	0.00152	CcSEcCtD
Cladribine—Confusional state—Bleomycin—melanoma	0.000422	0.00149	CcSEcCtD
Cladribine—Oedema—Bleomycin—melanoma	0.000418	0.00148	CcSEcCtD
Cladribine—Back pain—Temozolomide—melanoma	0.000418	0.00148	CcSEcCtD
Cladribine—Infection—Bleomycin—melanoma	0.000416	0.00147	CcSEcCtD
Cladribine—Anaemia—Carmustine—melanoma	0.000413	0.00146	CcSEcCtD
Cladribine—Nausea—Vemurafenib—melanoma	0.00041	0.00145	CcSEcCtD
Cladribine—Thrombocytopenia—Bleomycin—melanoma	0.00041	0.00145	CcSEcCtD
Cladribine—Myalgia—Dactinomycin—melanoma	0.000407	0.00144	CcSEcCtD
Cladribine—Discomfort—Dactinomycin—melanoma	0.000402	0.00142	CcSEcCtD
Cladribine—Ill-defined disorder—Temozolomide—melanoma	0.000401	0.00142	CcSEcCtD
Cladribine—Anaemia—Temozolomide—melanoma	0.0004	0.00141	CcSEcCtD
Cladribine—Anorexia—Bleomycin—melanoma	0.000399	0.00141	CcSEcCtD
Cladribine—Pancytopenia—Docetaxel—melanoma	0.000392	0.00139	CcSEcCtD
Cladribine—Hypotension—Bleomycin—melanoma	0.000391	0.00138	CcSEcCtD
Cladribine—Oedema—Dactinomycin—melanoma	0.00039	0.00138	CcSEcCtD
Cladribine—Malaise—Temozolomide—melanoma	0.00039	0.00138	CcSEcCtD
Cladribine—Infection—Dactinomycin—melanoma	0.000388	0.00137	CcSEcCtD
Cladribine—Neutropenia—Docetaxel—melanoma	0.000386	0.00136	CcSEcCtD
Cladribine—Thrombocytopenia—Dactinomycin—melanoma	0.000382	0.00135	CcSEcCtD
Cladribine—Musculoskeletal discomfort—Bleomycin—melanoma	0.000381	0.00135	CcSEcCtD
Cladribine—Chest pain—Carmustine—melanoma	0.000381	0.00135	CcSEcCtD
Cladribine—Myalgia—Carmustine—melanoma	0.000381	0.00135	CcSEcCtD
Cladribine—Anxiety—Carmustine—melanoma	0.00038	0.00134	CcSEcCtD
Cladribine—Cough—Temozolomide—melanoma	0.000377	0.00133	CcSEcCtD
Cladribine—Paraesthesia—Bleomycin—melanoma	0.000376	0.00133	CcSEcCtD
Cladribine—Dyspnoea—Bleomycin—melanoma	0.000373	0.00132	CcSEcCtD
Cladribine—Anorexia—Dactinomycin—melanoma	0.000372	0.00131	CcSEcCtD
Cladribine—Pneumonia—Docetaxel—melanoma	0.00037	0.00131	CcSEcCtD
Cladribine—ABCG2—lymph node—melanoma	0.000368	0.00372	CbGeAlD
Cladribine—Confusional state—Carmustine—melanoma	0.000368	0.0013	CcSEcCtD
Cladribine—Myalgia—Temozolomide—melanoma	0.000368	0.0013	CcSEcCtD
Cladribine—Arthralgia—Temozolomide—melanoma	0.000368	0.0013	CcSEcCtD
Cladribine—Infestation NOS—Docetaxel—melanoma	0.000368	0.0013	CcSEcCtD
Cladribine—Infestation—Docetaxel—melanoma	0.000368	0.0013	CcSEcCtD
Cladribine—Anxiety—Temozolomide—melanoma	0.000367	0.0013	CcSEcCtD
Cladribine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000366	0.00129	CcSEcCtD
Cladribine—Oedema—Carmustine—melanoma	0.000365	0.00129	CcSEcCtD
Cladribine—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000365	0.00129	CcSEcCtD
Cladribine—Discomfort—Temozolomide—melanoma	0.000364	0.00129	CcSEcCtD
Cladribine—Decreased appetite—Bleomycin—melanoma	0.000364	0.00129	CcSEcCtD
Cladribine—Infection—Carmustine—melanoma	0.000363	0.00128	CcSEcCtD
Cladribine—Renal failure—Docetaxel—melanoma	0.000362	0.00128	CcSEcCtD
Cladribine—Pain—Bleomycin—melanoma	0.000358	0.00126	CcSEcCtD
Cladribine—Conjunctivitis—Docetaxel—melanoma	0.000358	0.00126	CcSEcCtD
Cladribine—Thrombocytopenia—Carmustine—melanoma	0.000357	0.00126	CcSEcCtD
Cladribine—Tachycardia—Carmustine—melanoma	0.000356	0.00126	CcSEcCtD
Cladribine—Confusional state—Temozolomide—melanoma	0.000356	0.00126	CcSEcCtD
Cladribine—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000355	0.00126	CcSEcCtD
Cladribine—Oedema—Temozolomide—melanoma	0.000353	0.00125	CcSEcCtD
Cladribine—Infection—Temozolomide—melanoma	0.000351	0.00124	CcSEcCtD
Cladribine—Anorexia—Carmustine—melanoma	0.000348	0.00123	CcSEcCtD
Cladribine—Hepatobiliary disease—Docetaxel—melanoma	0.000348	0.00123	CcSEcCtD
Cladribine—Epistaxis—Docetaxel—melanoma	0.000347	0.00123	CcSEcCtD
Cladribine—Nervous system disorder—Temozolomide—melanoma	0.000346	0.00122	CcSEcCtD
Cladribine—Thrombocytopenia—Temozolomide—melanoma	0.000345	0.00122	CcSEcCtD
Cladribine—Feeling abnormal—Bleomycin—melanoma	0.000345	0.00122	CcSEcCtD
Cladribine—Skin disorder—Temozolomide—melanoma	0.000343	0.00121	CcSEcCtD
Cladribine—Hypotension—Carmustine—melanoma	0.000341	0.00121	CcSEcCtD
Cladribine—Hyperhidrosis—Temozolomide—melanoma	0.000341	0.00121	CcSEcCtD
Cladribine—Decreased appetite—Dactinomycin—melanoma	0.000339	0.0012	CcSEcCtD
Cladribine—Fatigue—Dactinomycin—melanoma	0.000336	0.00119	CcSEcCtD
Cladribine—Anorexia—Temozolomide—melanoma	0.000336	0.00119	CcSEcCtD
Cladribine—Pain—Dactinomycin—melanoma	0.000334	0.00118	CcSEcCtD
Cladribine—Musculoskeletal discomfort—Carmustine—melanoma	0.000333	0.00118	CcSEcCtD
Cladribine—Urticaria—Bleomycin—melanoma	0.000332	0.00117	CcSEcCtD
Cladribine—Haemoglobin—Docetaxel—melanoma	0.000332	0.00117	CcSEcCtD
Cladribine—Body temperature increased—Bleomycin—melanoma	0.000331	0.00117	CcSEcCtD
Cladribine—Haemorrhage—Docetaxel—melanoma	0.00033	0.00117	CcSEcCtD
Cladribine—Insomnia—Carmustine—melanoma	0.00033	0.00117	CcSEcCtD
Cladribine—Paraesthesia—Carmustine—melanoma	0.000328	0.00116	CcSEcCtD
Cladribine—Pharyngitis—Docetaxel—melanoma	0.000328	0.00116	CcSEcCtD
Cladribine—Urinary tract disorder—Docetaxel—melanoma	0.000326	0.00115	CcSEcCtD
Cladribine—Dyspnoea—Carmustine—melanoma	0.000326	0.00115	CcSEcCtD
Cladribine—Oedema peripheral—Docetaxel—melanoma	0.000325	0.00115	CcSEcCtD
Cladribine—Somnolence—Carmustine—melanoma	0.000325	0.00115	CcSEcCtD
Cladribine—Connective tissue disorder—Docetaxel—melanoma	0.000325	0.00115	CcSEcCtD
Cladribine—Urethral disorder—Docetaxel—melanoma	0.000324	0.00114	CcSEcCtD
Cladribine—Feeling abnormal—Dactinomycin—melanoma	0.000321	0.00114	CcSEcCtD
Cladribine—Musculoskeletal discomfort—Temozolomide—melanoma	0.000321	0.00114	CcSEcCtD
Cladribine—Insomnia—Temozolomide—melanoma	0.000319	0.00113	CcSEcCtD
Cladribine—Gastrointestinal pain—Dactinomycin—melanoma	0.000319	0.00113	CcSEcCtD
Cladribine—Decreased appetite—Carmustine—melanoma	0.000317	0.00112	CcSEcCtD
Cladribine—Paraesthesia—Temozolomide—melanoma	0.000317	0.00112	CcSEcCtD
Cladribine—Gastrointestinal disorder—Carmustine—melanoma	0.000315	0.00111	CcSEcCtD
Cladribine—Dyspnoea—Temozolomide—melanoma	0.000315	0.00111	CcSEcCtD
Cladribine—Somnolence—Temozolomide—melanoma	0.000314	0.00111	CcSEcCtD
Cladribine—Erythema multiforme—Docetaxel—melanoma	0.000312	0.0011	CcSEcCtD
Cladribine—Constipation—Carmustine—melanoma	0.000312	0.0011	CcSEcCtD
Cladribine—Pain—Carmustine—melanoma	0.000312	0.0011	CcSEcCtD
Cladribine—Eye disorder—Docetaxel—melanoma	0.000309	0.00109	CcSEcCtD
Cladribine—Abdominal pain—Dactinomycin—melanoma	0.000308	0.00109	CcSEcCtD
Cladribine—Body temperature increased—Dactinomycin—melanoma	0.000308	0.00109	CcSEcCtD
Cladribine—Hypersensitivity—Bleomycin—melanoma	0.000308	0.00109	CcSEcCtD
Cladribine—Decreased appetite—Temozolomide—melanoma	0.000307	0.00108	CcSEcCtD
Cladribine—Cardiac disorder—Docetaxel—melanoma	0.000307	0.00108	CcSEcCtD
Cladribine—Gastrointestinal disorder—Temozolomide—melanoma	0.000305	0.00108	CcSEcCtD
Cladribine—Fatigue—Temozolomide—melanoma	0.000304	0.00108	CcSEcCtD
Cladribine—Constipation—Temozolomide—melanoma	0.000302	0.00107	CcSEcCtD
Cladribine—Pain—Temozolomide—melanoma	0.000302	0.00107	CcSEcCtD
Cladribine—Feeling abnormal—Carmustine—melanoma	0.000301	0.00106	CcSEcCtD
Cladribine—Asthenia—Bleomycin—melanoma	0.0003	0.00106	CcSEcCtD
Cladribine—Angiopathy—Docetaxel—melanoma	0.0003	0.00106	CcSEcCtD
Cladribine—Gastrointestinal pain—Carmustine—melanoma	0.000299	0.00106	CcSEcCtD
Cladribine—Immune system disorder—Docetaxel—melanoma	0.000298	0.00105	CcSEcCtD
Cladribine—Mediastinal disorder—Docetaxel—melanoma	0.000298	0.00105	CcSEcCtD
Cladribine—Chills—Docetaxel—melanoma	0.000296	0.00105	CcSEcCtD
Cladribine—Pruritus—Bleomycin—melanoma	0.000296	0.00105	CcSEcCtD
Cladribine—Arrhythmia—Docetaxel—melanoma	0.000295	0.00104	CcSEcCtD
Cladribine—Alopecia—Docetaxel—melanoma	0.000292	0.00103	CcSEcCtD
Cladribine—Feeling abnormal—Temozolomide—melanoma	0.000291	0.00103	CcSEcCtD
Cladribine—Mental disorder—Docetaxel—melanoma	0.000289	0.00102	CcSEcCtD
Cladribine—Body temperature increased—Carmustine—melanoma	0.000289	0.00102	CcSEcCtD
Cladribine—Abdominal pain—Carmustine—melanoma	0.000289	0.00102	CcSEcCtD
Cladribine—Gastrointestinal pain—Temozolomide—melanoma	0.000289	0.00102	CcSEcCtD
Cladribine—Erythema—Docetaxel—melanoma	0.000288	0.00102	CcSEcCtD
Cladribine—Malnutrition—Docetaxel—melanoma	0.000288	0.00102	CcSEcCtD
Cladribine—Hypersensitivity—Dactinomycin—melanoma	0.000287	0.00102	CcSEcCtD
Cladribine—Urticaria—Temozolomide—melanoma	0.00028	0.000991	CcSEcCtD
Cladribine—Asthenia—Dactinomycin—melanoma	0.00028	0.00099	CcSEcCtD
Cladribine—Abdominal pain—Temozolomide—melanoma	0.000279	0.000986	CcSEcCtD
Cladribine—Body temperature increased—Temozolomide—melanoma	0.000279	0.000986	CcSEcCtD
Cladribine—Back pain—Docetaxel—melanoma	0.000278	0.000983	CcSEcCtD
Cladribine—Hypersensitivity—Carmustine—melanoma	0.000269	0.000951	CcSEcCtD
Cladribine—Diarrhoea—Dactinomycin—melanoma	0.000267	0.000944	CcSEcCtD
Cladribine—Vomiting—Bleomycin—melanoma	0.000266	0.00094	CcSEcCtD
Cladribine—Anaemia—Docetaxel—melanoma	0.000266	0.00094	CcSEcCtD
Cladribine—Rash—Bleomycin—melanoma	0.000264	0.000933	CcSEcCtD
Cladribine—Dermatitis—Bleomycin—melanoma	0.000263	0.000932	CcSEcCtD
Cladribine—Asthenia—Carmustine—melanoma	0.000262	0.000926	CcSEcCtD
Cladribine—Hypersensitivity—Temozolomide—melanoma	0.00026	0.000919	CcSEcCtD
Cladribine—Asthenia—Temozolomide—melanoma	0.000253	0.000895	CcSEcCtD
Cladribine—Cough—Docetaxel—melanoma	0.000251	0.000887	CcSEcCtD
Cladribine—Diarrhoea—Carmustine—melanoma	0.00025	0.000883	CcSEcCtD
Cladribine—Pruritus—Temozolomide—melanoma	0.00025	0.000883	CcSEcCtD
Cladribine—Nausea—Bleomycin—melanoma	0.000248	0.000879	CcSEcCtD
Cladribine—Vomiting—Dactinomycin—melanoma	0.000248	0.000877	CcSEcCtD
Cladribine—Rash—Dactinomycin—melanoma	0.000246	0.00087	CcSEcCtD
Cladribine—Chest pain—Docetaxel—melanoma	0.000245	0.000865	CcSEcCtD
Cladribine—Arthralgia—Docetaxel—melanoma	0.000245	0.000865	CcSEcCtD
Cladribine—Myalgia—Docetaxel—melanoma	0.000245	0.000865	CcSEcCtD
Cladribine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000243	0.00086	CcSEcCtD
Cladribine—Dizziness—Carmustine—melanoma	0.000241	0.000854	CcSEcCtD
Cladribine—Diarrhoea—Temozolomide—melanoma	0.000241	0.000854	CcSEcCtD
Cladribine—Confusional state—Docetaxel—melanoma	0.000237	0.000837	CcSEcCtD
Cladribine—Oedema—Docetaxel—melanoma	0.000235	0.00083	CcSEcCtD
Cladribine—Dizziness—Temozolomide—melanoma	0.000233	0.000825	CcSEcCtD
Cladribine—Infection—Docetaxel—melanoma	0.000233	0.000824	CcSEcCtD
Cladribine—Vomiting—Carmustine—melanoma	0.000232	0.000821	CcSEcCtD
Cladribine—Nausea—Dactinomycin—melanoma	0.000232	0.000819	CcSEcCtD
Cladribine—Rash—Carmustine—melanoma	0.00023	0.000814	CcSEcCtD
Cladribine—Nervous system disorder—Docetaxel—melanoma	0.00023	0.000814	CcSEcCtD
Cladribine—Dermatitis—Carmustine—melanoma	0.00023	0.000813	CcSEcCtD
Cladribine—Thrombocytopenia—Docetaxel—melanoma	0.00023	0.000812	CcSEcCtD
Cladribine—Tachycardia—Docetaxel—melanoma	0.000229	0.00081	CcSEcCtD
Cladribine—Headache—Carmustine—melanoma	0.000229	0.000809	CcSEcCtD
Cladribine—Skin disorder—Docetaxel—melanoma	0.000228	0.000806	CcSEcCtD
Cladribine—Vomiting—Temozolomide—melanoma	0.000224	0.000793	CcSEcCtD
Cladribine—Anorexia—Docetaxel—melanoma	0.000224	0.000791	CcSEcCtD
Cladribine—Rash—Temozolomide—melanoma	0.000222	0.000787	CcSEcCtD
Cladribine—Dermatitis—Temozolomide—melanoma	0.000222	0.000786	CcSEcCtD
Cladribine—Headache—Temozolomide—melanoma	0.000221	0.000782	CcSEcCtD
Cladribine—Hypotension—Docetaxel—melanoma	0.000219	0.000775	CcSEcCtD
Cladribine—Nausea—Carmustine—melanoma	0.000217	0.000767	CcSEcCtD
Cladribine—Musculoskeletal discomfort—Docetaxel—melanoma	0.000214	0.000756	CcSEcCtD
Cladribine—Insomnia—Docetaxel—melanoma	0.000212	0.00075	CcSEcCtD
Cladribine—Paraesthesia—Docetaxel—melanoma	0.000211	0.000745	CcSEcCtD
Cladribine—Nausea—Temozolomide—melanoma	0.00021	0.000741	CcSEcCtD
Cladribine—Dyspnoea—Docetaxel—melanoma	0.000209	0.00074	CcSEcCtD
Cladribine—Somnolence—Docetaxel—melanoma	0.000209	0.000738	CcSEcCtD
Cladribine—Decreased appetite—Docetaxel—melanoma	0.000204	0.000721	CcSEcCtD
Cladribine—Gastrointestinal disorder—Docetaxel—melanoma	0.000203	0.000716	CcSEcCtD
Cladribine—Fatigue—Docetaxel—melanoma	0.000202	0.000715	CcSEcCtD
Cladribine—Pain—Docetaxel—melanoma	0.000201	0.00071	CcSEcCtD
Cladribine—Constipation—Docetaxel—melanoma	0.000201	0.00071	CcSEcCtD
Cladribine—Feeling abnormal—Docetaxel—melanoma	0.000193	0.000684	CcSEcCtD
Cladribine—Gastrointestinal pain—Docetaxel—melanoma	0.000192	0.000678	CcSEcCtD
Cladribine—Abdominal pain—Docetaxel—melanoma	0.000185	0.000656	CcSEcCtD
Cladribine—Body temperature increased—Docetaxel—melanoma	0.000185	0.000656	CcSEcCtD
Cladribine—Hypersensitivity—Docetaxel—melanoma	0.000173	0.000611	CcSEcCtD
Cladribine—Asthenia—Docetaxel—melanoma	0.000168	0.000595	CcSEcCtD
Cladribine—Pruritus—Docetaxel—melanoma	0.000166	0.000587	CcSEcCtD
Cladribine—Diarrhoea—Docetaxel—melanoma	0.000161	0.000568	CcSEcCtD
Cladribine—Dizziness—Docetaxel—melanoma	0.000155	0.000549	CcSEcCtD
Cladribine—Vomiting—Docetaxel—melanoma	0.000149	0.000528	CcSEcCtD
Cladribine—Rash—Docetaxel—melanoma	0.000148	0.000523	CcSEcCtD
Cladribine—Dermatitis—Docetaxel—melanoma	0.000148	0.000523	CcSEcCtD
Cladribine—Headache—Docetaxel—melanoma	0.000147	0.00052	CcSEcCtD
Cladribine—Nausea—Docetaxel—melanoma	0.000139	0.000493	CcSEcCtD
Cladribine—RRM2B—Metabolism—PIK3CB—melanoma	3.99e-05	0.000137	CbGpPWpGaD
Cladribine—POLE2—Cell Cycle—MAPK1—melanoma	3.99e-05	0.000136	CbGpPWpGaD
Cladribine—PNP—Metabolism—PIK3CD—melanoma	3.97e-05	0.000136	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—PTGS2—melanoma	3.96e-05	0.000135	CbGpPWpGaD
Cladribine—RRM2—Metabolism—FASN—melanoma	3.95e-05	0.000135	CbGpPWpGaD
Cladribine—PNP—Metabolism—ALB—melanoma	3.92e-05	0.000134	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle—MDM2—melanoma	3.92e-05	0.000134	CbGpPWpGaD
Cladribine—RRM2—Metabolism—SLC5A5—melanoma	3.89e-05	0.000133	CbGpPWpGaD
Cladribine—POLE—Cell Cycle—CDKN2A—melanoma	3.88e-05	0.000133	CbGpPWpGaD
Cladribine—SLC22A2—Transmission across Chemical Synapses—BRAF—melanoma	3.85e-05	0.000132	CbGpPWpGaD
Cladribine—POLE—Mitotic M-M/G1 phases—MAPK1—melanoma	3.84e-05	0.000131	CbGpPWpGaD
Cladribine—POLE—Cell Cycle, Mitotic—CDKN1B—melanoma	3.84e-05	0.000131	CbGpPWpGaD
Cladribine—ABCG2—HIF-1-alpha transcription factor network—AKT1—melanoma	3.84e-05	0.000131	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—CDK2—melanoma	3.83e-05	0.000131	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle, Mitotic—CCND1—melanoma	3.82e-05	0.000131	CbGpPWpGaD
Cladribine—DCK—Metabolism—GNA11—melanoma	3.78e-05	0.000129	CbGpPWpGaD
Cladribine—POLE—Cell Cycle—MDM2—melanoma	3.76e-05	0.000129	CbGpPWpGaD
Cladribine—RRM2—Metabolism—GNAQ—melanoma	3.76e-05	0.000128	CbGpPWpGaD
Cladribine—RRM2—Metabolism—CD44—melanoma	3.76e-05	0.000128	CbGpPWpGaD
Cladribine—SLC22A1—Neuronal System—PRKCA—melanoma	3.74e-05	0.000128	CbGpPWpGaD
Cladribine—DCK—Metabolism—FASN—melanoma	3.7e-05	0.000126	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle, Mitotic—CDKN1A—melanoma	3.69e-05	0.000126	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	3.67e-05	0.000126	CbGpPWpGaD
Cladribine—POLE—Cell Cycle, Mitotic—CCND1—melanoma	3.66e-05	0.000125	CbGpPWpGaD
Cladribine—NR5A1—Developmental Biology—HRAS—melanoma	3.65e-05	0.000125	CbGpPWpGaD
Cladribine—DCK—Metabolism—SLC5A5—melanoma	3.63e-05	0.000124	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—ATM—melanoma	3.63e-05	0.000124	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—CDK4—melanoma	3.62e-05	0.000124	CbGpPWpGaD
Cladribine—RRM1—Metabolism—ABCB1—melanoma	3.6e-05	0.000123	CbGpPWpGaD
Cladribine—RRM2—Metabolism—CYP1B1—melanoma	3.6e-05	0.000123	CbGpPWpGaD
Cladribine—SLC22A1—Transmission across Chemical Synapses—BRAF—melanoma	3.59e-05	0.000123	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle—CDKN1B—melanoma	3.58e-05	0.000122	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	3.55e-05	0.000122	CbGpPWpGaD
Cladribine—POLE—Cell Cycle, Mitotic—CDKN1A—melanoma	3.55e-05	0.000121	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle, Mitotic—RB1—melanoma	3.52e-05	0.00012	CbGpPWpGaD
Cladribine—DCK—Metabolism—GNAQ—melanoma	3.51e-05	0.00012	CbGpPWpGaD
Cladribine—DCK—Metabolism—CD44—melanoma	3.51e-05	0.00012	CbGpPWpGaD
Cladribine—NR5A1—Developmental Biology—IL6—melanoma	3.49e-05	0.000119	CbGpPWpGaD
Cladribine—PNP—Metabolism—PIK3CB—melanoma	3.46e-05	0.000118	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—PTEN—melanoma	3.45e-05	0.000118	CbGpPWpGaD
Cladribine—POLE—Cell Cycle—CDKN1B—melanoma	3.43e-05	0.000117	CbGpPWpGaD
Cladribine—PNP—Metabolism—PTGS2—melanoma	3.43e-05	0.000117	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle—CCND1—melanoma	3.41e-05	0.000117	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—PLCB4—melanoma	3.38e-05	0.000116	CbGpPWpGaD
Cladribine—DCK—Metabolism—CYP1B1—melanoma	3.37e-05	0.000115	CbGpPWpGaD
Cladribine—POLE2—Cell Cycle—TP53—melanoma	3.35e-05	0.000115	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—PLCB4—melanoma	3.35e-05	0.000115	CbGpPWpGaD
Cladribine—RRM1—Metabolism—PRKCA—melanoma	3.31e-05	0.000113	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle—CDKN1A—melanoma	3.3e-05	0.000113	CbGpPWpGaD
Cladribine—RRM1—Metabolism—ERCC2—melanoma	3.29e-05	0.000112	CbGpPWpGaD
Cladribine—POLE—Cell Cycle—CCND1—melanoma	3.28e-05	0.000112	CbGpPWpGaD
Cladribine—SLC22A2—Transmission across Chemical Synapses—MDM2—melanoma	3.23e-05	0.00011	CbGpPWpGaD
Cladribine—NR5A1—Developmental Biology—AKT1—melanoma	3.22e-05	0.00011	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—PIP4K2A—melanoma	3.18e-05	0.000109	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—SLC6A11—melanoma	3.18e-05	0.000109	CbGpPWpGaD
Cladribine—POLE—Cell Cycle—CDKN1A—melanoma	3.17e-05	0.000108	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle, Mitotic—MAPK3—melanoma	3.15e-05	0.000108	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—PIP4K2A—melanoma	3.15e-05	0.000108	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—SLC6A11—melanoma	3.15e-05	0.000108	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—RB1—melanoma	3.14e-05	0.000108	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—PLCB4—melanoma	3.12e-05	0.000107	CbGpPWpGaD
Cladribine—ABCG2—Transmembrane transport of small molecules—SLC5A5—melanoma	3.11e-05	0.000106	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—MTAP—melanoma	3.09e-05	0.000106	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle, Mitotic—CDKN2A—melanoma	3.09e-05	0.000106	CbGpPWpGaD
Cladribine—SLC22A2—Transmembrane transport of small molecules—SLC5A5—melanoma	3.07e-05	0.000105	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—MTAP—melanoma	3.06e-05	0.000105	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle, Mitotic—MYC—melanoma	3.06e-05	0.000105	CbGpPWpGaD
Cladribine—POLE—Cell Cycle, Mitotic—MAPK3—melanoma	3.02e-05	0.000103	CbGpPWpGaD
Cladribine—SLC22A1—Transmission across Chemical Synapses—MDM2—melanoma	3.01e-05	0.000103	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	3e-05	0.000103	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle, Mitotic—MAPK1—melanoma	3e-05	0.000102	CbGpPWpGaD
Cladribine—PNP—Metabolism—PTEN—melanoma	2.99e-05	0.000102	CbGpPWpGaD
Cladribine—RRM2—Metabolism—ABCB1—melanoma	2.97e-05	0.000101	CbGpPWpGaD
Cladribine—SLC22A2—Neuronal System—BRAF—melanoma	2.95e-05	0.000101	CbGpPWpGaD
Cladribine—POLE—Cell Cycle, Mitotic—MYC—melanoma	2.94e-05	0.000101	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—PIP4K2A—melanoma	2.93e-05	0.0001	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—SLC6A11—melanoma	2.93e-05	0.0001	CbGpPWpGaD
Cladribine—SLC22A2—SLC-mediated transmembrane transport—ALB—melanoma	2.89e-05	9.87e-05	CbGpPWpGaD
Cladribine—POLA1—Mitotic M-M/G1 phases—MAPK3—melanoma	2.88e-05	9.85e-05	CbGpPWpGaD
Cladribine—POLE—Cell Cycle, Mitotic—MAPK1—melanoma	2.88e-05	9.83e-05	CbGpPWpGaD
Cladribine—SLC22A1—Transmembrane transport of small molecules—SLC5A5—melanoma	2.86e-05	9.8e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—MTAP—melanoma	2.85e-05	9.76e-05	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle—MAPK3—melanoma	2.82e-05	9.63e-05	CbGpPWpGaD
Cladribine—DCK—Metabolism—ABCB1—melanoma	2.77e-05	9.48e-05	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—CDKN2A—melanoma	2.76e-05	9.45e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—PHGDH—melanoma	2.76e-05	9.43e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—LUM—melanoma	2.76e-05	9.43e-05	CbGpPWpGaD
Cladribine—SLC22A1—Neuronal System—BRAF—melanoma	2.75e-05	9.41e-05	CbGpPWpGaD
Cladribine—POLA1—Mitotic M-M/G1 phases—MAPK1—melanoma	2.74e-05	9.37e-05	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle—MYC—melanoma	2.74e-05	9.36e-05	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle, Mitotic—CDKN1B—melanoma	2.74e-05	9.36e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—LUM—melanoma	2.73e-05	9.33e-05	CbGpPWpGaD
Cladribine—RRM2—Metabolism—PRKCA—melanoma	2.73e-05	9.33e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—PHGDH—melanoma	2.73e-05	9.33e-05	CbGpPWpGaD
Cladribine—RRM2—Metabolism—ERCC2—melanoma	2.71e-05	9.26e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—HPSE—melanoma	2.7e-05	9.25e-05	CbGpPWpGaD
Cladribine—POLE—Cell Cycle—MAPK3—melanoma	2.7e-05	9.24e-05	CbGpPWpGaD
Cladribine—SLC22A1—SLC-mediated transmembrane transport—ALB—melanoma	2.69e-05	9.2e-05	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—MDM2—melanoma	2.68e-05	9.17e-05	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle—MAPK1—melanoma	2.68e-05	9.16e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—HPSE—melanoma	2.68e-05	9.15e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—CUBN—melanoma	2.65e-05	9.08e-05	CbGpPWpGaD
Cladribine—POLE—Cell Cycle—MYC—melanoma	2.63e-05	8.99e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—CUBN—melanoma	2.63e-05	8.99e-05	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle, Mitotic—CCND1—melanoma	2.61e-05	8.93e-05	CbGpPWpGaD
Cladribine—RRM1—Metabolism—PIK3CG—melanoma	2.6e-05	8.88e-05	CbGpPWpGaD
Cladribine—POLE—Cell Cycle—MAPK1—melanoma	2.57e-05	8.79e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—SDHD—melanoma	2.56e-05	8.77e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—BSG—melanoma	2.56e-05	8.77e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—CSPG4—melanoma	2.56e-05	8.77e-05	CbGpPWpGaD
Cladribine—DCK—Metabolism—PRKCA—melanoma	2.55e-05	8.72e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—PHGDH—melanoma	2.54e-05	8.7e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—LUM—melanoma	2.54e-05	8.7e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—BSG—melanoma	2.54e-05	8.68e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—SDHD—melanoma	2.54e-05	8.68e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—CSPG4—melanoma	2.54e-05	8.68e-05	CbGpPWpGaD
Cladribine—DCK—Metabolism—ERCC2—melanoma	2.53e-05	8.65e-05	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle, Mitotic—CDKN1A—melanoma	2.53e-05	8.64e-05	CbGpPWpGaD
Cladribine—RRM1—Metabolism—PPARG—melanoma	2.51e-05	8.57e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—HPSE—melanoma	2.49e-05	8.53e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—GPAM—melanoma	2.48e-05	8.49e-05	CbGpPWpGaD
Cladribine—SLC22A2—Neuronal System—MDM2—melanoma	2.47e-05	8.46e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—GPAM—melanoma	2.46e-05	8.4e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—CUBN—melanoma	2.45e-05	8.37e-05	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—CDKN1B—melanoma	2.45e-05	8.37e-05	CbGpPWpGaD
Cladribine—NR5A1—Gene Expression—MAPK3—melanoma	2.44e-05	8.36e-05	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—PIK3CA—melanoma	2.44e-05	8.33e-05	CbGpPWpGaD
Cladribine—NR5A1—Gene Expression—MYC—melanoma	2.38e-05	8.13e-05	CbGpPWpGaD
Cladribine—ABCG2—Transmembrane transport of small molecules—ABCB1—melanoma	2.37e-05	8.1e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—CSPG4—melanoma	2.37e-05	8.09e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—BSG—melanoma	2.37e-05	8.09e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—SDHD—melanoma	2.37e-05	8.09e-05	CbGpPWpGaD
Cladribine—SLC22A2—Transmembrane transport of small molecules—ABCB1—melanoma	2.34e-05	8.01e-05	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—CCND1—melanoma	2.33e-05	7.98e-05	CbGpPWpGaD
Cladribine—SLC22A1—Neuronal System—MDM2—melanoma	2.31e-05	7.89e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—GPAM—melanoma	2.29e-05	7.83e-05	CbGpPWpGaD
Cladribine—RRM1—Metabolism—PIK3CD—melanoma	2.28e-05	7.81e-05	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—CDKN1A—melanoma	2.26e-05	7.72e-05	CbGpPWpGaD
Cladribine—RRM1—Metabolism—ALB—melanoma	2.25e-05	7.7e-05	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle—TP53—melanoma	2.25e-05	7.69e-05	CbGpPWpGaD
Cladribine—SLC22A2—Transmission across Chemical Synapses—MAPK1—melanoma	2.21e-05	7.55e-05	CbGpPWpGaD
Cladribine—SLC22A1—Transmembrane transport of small molecules—ABCB1—melanoma	2.18e-05	7.47e-05	CbGpPWpGaD
Cladribine—POLE—Cell Cycle—TP53—melanoma	2.16e-05	7.38e-05	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle, Mitotic—MAPK3—melanoma	2.15e-05	7.36e-05	CbGpPWpGaD
Cladribine—RRM2—Metabolism—PIK3CG—melanoma	2.14e-05	7.31e-05	CbGpPWpGaD
Cladribine—PNP—Metabolism—PIK3CA—melanoma	2.11e-05	7.22e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—PLA2G6—melanoma	2.11e-05	7.22e-05	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle, Mitotic—MYC—melanoma	2.09e-05	7.16e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—PLA2G6—melanoma	2.09e-05	7.15e-05	CbGpPWpGaD
Cladribine—RRM2—Metabolism—PPARG—melanoma	2.06e-05	7.06e-05	CbGpPWpGaD
Cladribine—SLC22A1—Transmission across Chemical Synapses—MAPK1—melanoma	2.06e-05	7.04e-05	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle, Mitotic—MAPK1—melanoma	2.05e-05	7.01e-05	CbGpPWpGaD
Cladribine—DCK—Metabolism—PIK3CG—melanoma	2e-05	6.83e-05	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—AKT1—melanoma	1.99e-05	6.8e-05	CbGpPWpGaD
Cladribine—RRM1—Metabolism—PIK3CB—melanoma	1.99e-05	6.8e-05	CbGpPWpGaD
Cladribine—RRM1—Metabolism—PTGS2—melanoma	1.97e-05	6.74e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—PLA2G6—melanoma	1.95e-05	6.66e-05	CbGpPWpGaD
Cladribine—DCK—Metabolism—PPARG—melanoma	1.93e-05	6.59e-05	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—MAPK3—melanoma	1.93e-05	6.59e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—VCAN—melanoma	1.9e-05	6.49e-05	CbGpPWpGaD
Cladribine—RRM2—Metabolism—PIK3CD—melanoma	1.88e-05	6.43e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—VCAN—melanoma	1.88e-05	6.42e-05	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—MYC—melanoma	1.87e-05	6.4e-05	CbGpPWpGaD
Cladribine—RRM2—Metabolism—ALB—melanoma	1.86e-05	6.34e-05	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—MAPK1—melanoma	1.83e-05	6.27e-05	CbGpPWpGaD
Cladribine—SLC22A2—Transmission across Chemical Synapses—HRAS—melanoma	1.77e-05	6.06e-05	CbGpPWpGaD
Cladribine—DCK—Metabolism—PIK3CD—melanoma	1.76e-05	6.01e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—VCAN—melanoma	1.75e-05	5.98e-05	CbGpPWpGaD
Cladribine—DCK—Metabolism—ALB—melanoma	1.73e-05	5.93e-05	CbGpPWpGaD
Cladribine—PNP—Metabolism—AKT1—melanoma	1.72e-05	5.9e-05	CbGpPWpGaD
Cladribine—RRM1—Metabolism—PTEN—melanoma	1.72e-05	5.88e-05	CbGpPWpGaD
Cladribine—SLC22A2—Neuronal System—MAPK1—melanoma	1.69e-05	5.78e-05	CbGpPWpGaD
Cladribine—SLC22A1—Transmission across Chemical Synapses—HRAS—melanoma	1.65e-05	5.65e-05	CbGpPWpGaD
Cladribine—NR5A1—Gene Expression—AKT1—melanoma	1.65e-05	5.64e-05	CbGpPWpGaD
Cladribine—RRM2—Metabolism—PIK3CB—melanoma	1.64e-05	5.6e-05	CbGpPWpGaD
Cladribine—RRM2—Metabolism—PTGS2—melanoma	1.62e-05	5.55e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—CYP17A1—melanoma	1.6e-05	5.47e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—CYP17A1—melanoma	1.58e-05	5.42e-05	CbGpPWpGaD
Cladribine—SLC22A1—Neuronal System—MAPK1—melanoma	1.58e-05	5.39e-05	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—TP53—melanoma	1.54e-05	5.26e-05	CbGpPWpGaD
Cladribine—DCK—Metabolism—PIK3CB—melanoma	1.53e-05	5.24e-05	CbGpPWpGaD
Cladribine—DCK—Metabolism—PTGS2—melanoma	1.52e-05	5.19e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—GNA11—melanoma	1.51e-05	5.17e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—GNA11—melanoma	1.5e-05	5.11e-05	CbGpPWpGaD
Cladribine—ABCG2—Transmembrane transport of small molecules—ALB—melanoma	1.48e-05	5.07e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—FASN—melanoma	1.48e-05	5.06e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—CYP17A1—melanoma	1.48e-05	5.05e-05	CbGpPWpGaD
Cladribine—SLC22A2—Transmembrane transport of small molecules—ALB—melanoma	1.47e-05	5.01e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—FASN—melanoma	1.46e-05	5e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—SLC5A5—melanoma	1.45e-05	4.97e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—SLC5A5—melanoma	1.44e-05	4.92e-05	CbGpPWpGaD
Cladribine—RRM2—Metabolism—PTEN—melanoma	1.42e-05	4.84e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—GNAQ—melanoma	1.4e-05	4.8e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—CD44—melanoma	1.4e-05	4.8e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—GNA11—melanoma	1.39e-05	4.77e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—GNAQ—melanoma	1.39e-05	4.75e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—CD44—melanoma	1.39e-05	4.75e-05	CbGpPWpGaD
Cladribine—SLC22A1—Transmembrane transport of small molecules—ALB—melanoma	1.37e-05	4.67e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—FASN—melanoma	1.36e-05	4.66e-05	CbGpPWpGaD
Cladribine—SLC22A2—Neuronal System—HRAS—melanoma	1.36e-05	4.64e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—CYP1B1—melanoma	1.35e-05	4.61e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—SLC5A5—melanoma	1.34e-05	4.59e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—CYP1B1—melanoma	1.33e-05	4.56e-05	CbGpPWpGaD
Cladribine—DCK—Metabolism—PTEN—melanoma	1.32e-05	4.52e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—CD44—melanoma	1.3e-05	4.43e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—GNAQ—melanoma	1.3e-05	4.43e-05	CbGpPWpGaD
Cladribine—SLC22A1—Neuronal System—HRAS—melanoma	1.27e-05	4.33e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—CYP1B1—melanoma	1.24e-05	4.25e-05	CbGpPWpGaD
Cladribine—RRM1—Metabolism—PIK3CA—melanoma	1.21e-05	4.15e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—ABCB1—melanoma	1.11e-05	3.79e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—ABCB1—melanoma	1.1e-05	3.75e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—ABCB1—melanoma	1.02e-05	3.5e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—PRKCA—melanoma	1.02e-05	3.49e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—ERCC2—melanoma	1.01e-05	3.46e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—PRKCA—melanoma	1.01e-05	3.45e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—ERCC2—melanoma	1e-05	3.43e-05	CbGpPWpGaD
Cladribine—RRM2—Metabolism—PIK3CA—melanoma	9.99e-06	3.42e-05	CbGpPWpGaD
Cladribine—RRM1—Metabolism—AKT1—melanoma	9.91e-06	3.39e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—PRKCA—melanoma	9.42e-06	3.22e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—ERCC2—melanoma	9.34e-06	3.19e-05	CbGpPWpGaD
Cladribine—DCK—Metabolism—PIK3CA—melanoma	9.33e-06	3.19e-05	CbGpPWpGaD
Cladribine—RRM2—Metabolism—AKT1—melanoma	8.16e-06	2.79e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—PIK3CG—melanoma	8e-06	2.73e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—PIK3CG—melanoma	7.91e-06	2.71e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—PPARG—melanoma	7.72e-06	2.64e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—PPARG—melanoma	7.64e-06	2.61e-05	CbGpPWpGaD
Cladribine—DCK—Metabolism—AKT1—melanoma	7.62e-06	2.61e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—PIK3CG—melanoma	7.37e-06	2.52e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—PPARG—melanoma	7.12e-06	2.43e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—PIK3CD—melanoma	7.03e-06	2.4e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—PIK3CD—melanoma	6.96e-06	2.38e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—ALB—melanoma	6.94e-06	2.37e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—ALB—melanoma	6.87e-06	2.35e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—PIK3CD—melanoma	6.48e-06	2.22e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—ALB—melanoma	6.4e-06	2.19e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—PIK3CB—melanoma	6.13e-06	2.1e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—PTGS2—melanoma	6.07e-06	2.08e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—PIK3CB—melanoma	6.06e-06	2.07e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—PTGS2—melanoma	6.01e-06	2.05e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—PIK3CB—melanoma	5.65e-06	1.93e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—PTGS2—melanoma	5.6e-06	1.91e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—PTEN—melanoma	5.29e-06	1.81e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—PTEN—melanoma	5.24e-06	1.79e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—PTEN—melanoma	4.88e-06	1.67e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—PIK3CA—melanoma	3.73e-06	1.28e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—PIK3CA—melanoma	3.7e-06	1.26e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—PIK3CA—melanoma	3.44e-06	1.18e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—AKT1—melanoma	3.05e-06	1.04e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—AKT1—melanoma	3.02e-06	1.03e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—AKT1—melanoma	2.81e-06	9.62e-06	CbGpPWpGaD
